PHARMASUM THERAPEUTICS
Pharmasum Therapeutics AS is a private Norwegian specialty pharmaceutical company focused on the discovery and development of differentiated drugs for the treatment of autoimmune / metabolic and neurological diseases. Founded in 2014 on the spin-out of industrial research on protein kinases, Pharmasum has offices in Tromsø and Oslo in Norway, and representation in the UK and USA. The company has an experienced management, board and international team of advisors.
PHARMASUM THERAPEUTICS
Industry:
Pharmaceutical
Founded:
2014-01-01
Address:
Tromsø, Troms, Norway
Country:
Norway
Website Url:
http://www.pharmasum.com
Total Employee:
1+
Status:
Active
Contact:
+47 92 48 14 32
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome Euro ReCAPTCHA Cloudflare JS CDN JS AJAX Libraries API ReCAPTCHA V2
Current Employees Featured
Founder
Official Site Inspections
http://www.pharmasum.com
- Host name: 104.18.22.21
- IP address: 104.18.22.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pharmasum Therapeutics"
Pharmasum Therapeutics - Home
Sept 27 – 29, 2022 Pharmasum Therapeutics presented at Nordic Life Science Days (NLSD) READ MORE >> Jul 19, 2022 Pharmasum Therapeutics announces the publication of an …See details»
Pharmasum Therapeutics - Crunchbase Company Profile & Funding
Pharmasum Therapeutics AS is a private Norwegian specialty pharmaceutical company focused on the discovery and development of differentiated drugs for the treatment of autoimmune / …See details»
Pharmasum Therapeutics – Invester med hjertet for hjernen
Pharmasum Therapeutics is developing a drug representing a unique innovation in a global market, serving an extremely high unmet medical need. The Most Common Disease of Our …See details»
Pharmasum Therapeutics - Investors
Anders Fugelli. CEO Pharmasum Therapeutics. Phone: +47 924 81 432. Email: [email protected]See details»
Pharmasum Therapeutics AS: Drug pipelines, Patents, Clinical trials ...
Jul 15, 2023 Explore Pharmasum Therapeutics AS with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous …See details»
Pharmasum Therapeutics - Pharmaceutical Companies Database
Pharmasum Therapeutics is a private Norwegian pharmaceutical company focused on the discovery and development of novel drugs for treatment of neurological and …See details»
Pharmasum Therapeutics - Contacts, Employees, Board Members, …
A pharmaceutical company developing drugs for autoimmune/metabolic and neurological diseasesSee details»
Pharmasum Therapeutics - Norway Health Tech
A pharmaceutical company developing drugs for neurological and autoimmune/metabolic diseases. Pharmasum Therapeutics is a private Norwegian pharmaceutical company focused …See details»
Pharmasum Therapeutics AS - 913 746 430 - Oslo - Proff
Pharmasum Therapeutics AS. Org nr 913 746 430. Telefon 924 81 432. Adresse Gaustadalléen 21, 0349 Oslo. Sammenlign Overvåk Finn lignende. Del profil. Oversikt Regnskap Nøkkeltall …See details»
Pharmasum Therapeutics AS - The Hub
Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, …See details»
T&C – Pharmasum Therapeutics
Pharmasum Therapeutics AS is not responsible or liable for any omissions, errors or inaccuracies in any data or information posted or contained on this site, including but not limited to, product …See details»
pharmasum.com - Pharmasum Therapeutics - Home - Pharmasum …
Pharmasum.com most likely does not offer any adult content. Popular pages. Pharmasum Therapeutics - Home. Nov 17, 2021 Pharmasum Therapeutics announces the publication of …See details»
Pharmasum Therapeutics - The Science behind Pharmasum
Technology | The Science behind Pharmasum Biological processes at the level of enzymes, receptors, ion channels, etc. are regulated via protein phosphorylation catalysed by protein …See details»
Technology – Scientific Approach – Pharmasum Therapeutics
Pharmasum Therapeutics has developed PST-674 by using advanced drug design technologies. In collaboration with The Arctic University in Tromsø (UiT), extensive X-ray crystallographic …See details»
PST-1000 - Drug Targets, Indications, Patents - Synapse - Patsnap
Last update 01 Nov 2024. PST-1000. Last update 01 Nov 2024See details»
Pharmasum Therapeutics in Norway - ICH GCP
Pharmasum Therapeutics is a private Norwegian pharmaceutical company focused on the discovery and development of novel drugs for treatment of neurological and …See details»
The Most Common Disease Of Our Time – Pharmasum Therapeutics
The total estimated worldwide cost of dementia is enormous – over 1.3 trillion USD (Alzheimer’s Disease International). More than 1% of the annual global value creation is spent on nursing …See details»
Patients – Clinical Approach – Pharmasum Therapeutics
The PoC study will be a Phase 1b/2a study in individuals with Down syndrome and dementia. Since there is a close link between DYRK1A and dementia in Down syndrome, this is an ideal …See details»
Pharmasum Therapeutics - T&C
Pharmasum Therapeutics AS is not responsible or liable for any omissions, errors or inaccuracies in any data or information posted or contained on this site, including but not limited to, product …See details»
Pharmasum Therapeutics - Diabetes
Diabetes is a serious condition which can carry a significant risk of both short-term and long-term complications. Growing epidemic with staggering costsSee details»